Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade
YT Tsai, J Schlom, RN Donahue - Journal of Experimental & Clinical …, 2024 - Springer
The paradigm of non-small cell lung cancer (NSCLC) treatment has been profoundly
influenced by the development of immune checkpoint inhibitors (ICI), but the range of clinical …
influenced by the development of immune checkpoint inhibitors (ICI), but the range of clinical …
Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours
M Goswami, NJ Toney, SC Pitts… - Clinical and …, 2024 - Wiley Online Library
Background With the rapid adoption of immunotherapy for the treatment of cancer comes the
pressing need for readily accessible biomarkers to guide immunotherapeutic strategies and …
pressing need for readily accessible biomarkers to guide immunotherapeutic strategies and …
Peripheral CX3CR1+ T cells combined with PD-1 blockade therapy potentiates the anti-tumor efficacy for lung cancer
C Li, Z Zhang, Q Cai, Q Zhao, H Wu, JR Li, Y Liu… - …, 2024 - Taylor & Francis
Identifying tumor-relevant T cell subsets in the peripheral blood (PB) has become a potential
strategy for cancer treatment. However, the subset of PB that could be used to treat cancer …
strategy for cancer treatment. However, the subset of PB that could be used to treat cancer …
Peripheral blood biomarkers associated with combination of immune checkpoint blockade plus chemotherapy in NSCLC
N Kimura, Y Tsukita, R Ebina-Shibuya… - Cancer …, 2024 - content.iospress.com
BACKGROUND: Biomarkers predicting clinical outcomes of treating non-small cell lung
cancer (NSCLC) with combination of immune checkpoint inhibitors (ICIs) and chemotherapy …
cancer (NSCLC) with combination of immune checkpoint inhibitors (ICIs) and chemotherapy …
Generation, transcriptomic states, and clinical relevance of CX3CR1+ CD8 T cells in melanoma
Recent progress in single-cell profiling technologies has revealed significant phenotypic
and transcriptional heterogeneity in tumor-infiltrating CD8+ T cells. However, the transition …
and transcriptional heterogeneity in tumor-infiltrating CD8+ T cells. However, the transition …
[HTML][HTML] Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patients
Colorectal cancer (CRC) is one of the most frequently occurring cancers, but prognostic
biomarkers identifying patients at risk of recurrence are still lacking. In this study, we aimed …
biomarkers identifying patients at risk of recurrence are still lacking. In this study, we aimed …